NatWest Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-17,575
Closed -$659K 267
2015
Q3
$659K Buy
+17,575
New +$659K 0.01% 240
2015
Q2
Sell
-17,575
Closed -$622K 410
2015
Q1
$622K Buy
17,575
+929
+6% +$32.9K 0.01% 290
2014
Q4
$567 Sell
16,646
-11,420
-41% -$389 ﹤0.01% 297
2014
Q3
$1.08K Sell
28,066
-9,563
-25% -$369 0.01% 249
2014
Q2
$1.46M Sell
37,629
-17,361
-32% -$675K 0.06% 225
2014
Q1
$1.88M Sell
54,990
-1,230
-2% -$42.1K 0.08% 179
2013
Q4
$1.18M Buy
56,220
+5,961
+12% +$125K 0.03% 393
2013
Q3
$1.18M Buy
50,259
+18,562
+59% +$436K 0.03% 372
2013
Q2
$852K Buy
+31,697
New +$852K 0.01% 490